Clinical Trial Update: Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lapatinib in combination with chemotherapy for relapsed breast cancer; the study was terminated with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Relapsed Breast Cancer, Neoplasms, Breast | Phase 2 | Status: TERMINATED | Results posted: 2010-06-02